Skip to content

An interventional clinical trial to see effect of homoeopathic medicine in reproductive age group female with abnormal uterine bleeding

EFFECT OF INDIVIDUALIZED HOMOEOPATHIC MEDICINES IN FIFTY MILLESIMAL POTENCY IN ABNORMAL UTERINE BLEEDING WITH IT S MIASMATIC ANALYSIS IN REPRODUCTIVE AGE GROUP FEMALES: A PROSPECTIVE STUDY - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/05/087047
Enrollment
34
Registered
2025-05-16
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N939- Abnormal uterine and vaginal bleeding, unspecified

Interventions

Intervention1: Individualized homoeopathic medicines in fifty millesimal potency with concomitant care.: Intervention was planned as administering indicated homeopathic medicines in 50 millesimal pot

Sponsors

The Calcutta Homoeopathic Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patients fitting in the definition of AUB cases [(ICD-11-GA2Y)] more than 6 months. 2) Patients with age varying from 18 to 49 years. 3) Patients who can read or understand English, Bengali, Hindi.

Exclusion criteria

Exclusion criteria: 1) Patient not willing to participate in study. 2) Pregnant, Puerperal women, Lactating mothers. 3) Patients having IUCD in situ. 4) Non-menstrual & non uterine causes for bleeding (Foreign bodies, genital malignancy, abortion, post coital). 5) Patients having haemoglobin less than 8 gm/dl [44]. 6) Patients already undergoing any other treatment for AUB or any chronic diseases especially in last 6 weeks. 7) Patients already diagnosed of unstable psychiatric illness or other systemic diseases affecting quality of life. 8) Patients having any habits of substance abuse and addiction. 9) Simultaneous participation in any other clinical trial.

Design outcomes

Primary

MeasureTime frame
To see changes in Pictorial Blood Assessment Chart (PBAC) Score after 6 months of intervention.Timepoint: At baseline, every 4 weeks, up to 6 months

Secondary

MeasureTime frame
1. To detect the predominant miasm in cases with Abnormal uterine bleeding (AUB). 2. Changes in Short Form-36 Health Survey Questionnaire 1.0. 3. To ascertain and shortlist the most frequently indicated homoeopathic medicines in the treatment of AUB.Timepoint: At baseline, every 4 weeks, up to 6 months

Countries

India

Contacts

Public ContactNayab Amir

The Calcutta Homoeopathic Medical College and Hospital

dralok1974ghosh@gmail.com9836584268

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026